+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

Germany Precision Medicine and Genomics Market - Product Thumbnail Image

Germany Precision Medicine and Genomics Market

  • Report
  • September 2025
  • 95 Pages
  • Germany
From
UK AI-Powered Drug Discovery Platforms Market - Product Thumbnail Image

UK AI-Powered Drug Discovery Platforms Market

  • Report
  • September 2025
  • 88 Pages
  • United Kingdom
From
UK Genomics & Personalized Medicine Market - Product Thumbnail Image

UK Genomics & Personalized Medicine Market

  • Report
  • September 2025
  • 81 Pages
  • United Kingdom
From
South America Genomics Market Outlook, 2030 - Product Thumbnail Image

South America Genomics Market Outlook, 2030

  • Report
  • June 2025
  • 81 Pages
From
Japan Genomics Market Overview, 2030 - Product Thumbnail Image

Japan Genomics Market Overview, 2030

  • Report
  • June 2025
  • 77 Pages
  • Japan
From
Innovation Insights: Engineered Exosomes - Product Thumbnail Image

Innovation Insights: Engineered Exosomes

  • Report
  • January 2025
  • 50 Pages
  • Global
From
Innovation Insights: siRNA gene silencing - Product Thumbnail Image

Innovation Insights: siRNA gene silencing

  • Report
  • January 2025
  • 53 Pages
  • Global
From
From
Biopharmaceutical Market Outlook to 2029 - Product Thumbnail Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • September 2024
  • 97 Pages
  • Global
From
USA Molecular Weight Marker Market Outlook to 2028 - Product Thumbnail Image

USA Molecular Weight Marker Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
Biomarkers in Drug Development - Product Thumbnail Image

Biomarkers in Drug Development

  • Training
  • 60 Minutes
  • Global
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more